Skip to main content
Top
Published in: Breast Cancer Research 4/2011

01-08-2011 | Viewpoint

Cannibalism, cell survival, and endocrine resistance in breast cancer

Author: Robert Clarke

Published in: Breast Cancer Research | Issue 4/2011

Login to get access

Abstract

Breast cancer cells often respond to an endocrine therapy by altering expression of specific estrogen-responsive genes and inducing autophagy, a cannibalistic lysosomal pathway. Autophagy eliminates damaged or other organelles, allowing the recovery of the energy stored in their macromolecules to attempt restoration of metabolic homeostasis. Induction of autophagy can result from activation of the unfolded protein response following metabolic stress, the final cell fate often being determined by the extent and duration of autophagy. A study by Gonzalez-Malerva and colleagues builds upon this extensive knowledge, adding HSPB8 to the list of altered genes associated with endocrine resistance in breast cancer and describing the ability of HSPB8 to regulate autophagy and confer tamoxifen resistance.
Literature
1.
go back to reference Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet. 1998, 351: 1451-1467.CrossRef Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet. 1998, 351: 1451-1467.CrossRef
2.
go back to reference Musgrove EA, Sutherland RL: Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer. 2009, 9: 631-643. 10.1038/nrc2713.CrossRefPubMed Musgrove EA, Sutherland RL: Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer. 2009, 9: 631-643. 10.1038/nrc2713.CrossRefPubMed
3.
go back to reference Gu Z, Lee RY, Skaar TC, Bouker KB, Welch JN, Lu J, Liu A, Zhu Y, Davis N, Leonessa F, Brunner N, Wang Y, Clarke R: Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-κB, and cyclic AMP response element binding with acquired resistance to faslodex (ICI 182,780). Cancer Res. 2002, 62: 3428-3437.PubMed Gu Z, Lee RY, Skaar TC, Bouker KB, Welch JN, Lu J, Liu A, Zhu Y, Davis N, Leonessa F, Brunner N, Wang Y, Clarke R: Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-κB, and cyclic AMP response element binding with acquired resistance to faslodex (ICI 182,780). Cancer Res. 2002, 62: 3428-3437.PubMed
4.
go back to reference Clarke R, Shajahan AN, Riggins R, Cho Y, Crawford AC, Xuan J, Wang Y, Zwart A, Nehra N, Liu MC: Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells. J Steroid Biochem Mol Biol. 2009, 114: 8-20. 10.1016/j.jsbmb.2008.12.023.CrossRefPubMedPubMedCentral Clarke R, Shajahan AN, Riggins R, Cho Y, Crawford AC, Xuan J, Wang Y, Zwart A, Nehra N, Liu MC: Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells. J Steroid Biochem Mol Biol. 2009, 114: 8-20. 10.1016/j.jsbmb.2008.12.023.CrossRefPubMedPubMedCentral
5.
go back to reference Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A: DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol. 2002, 157: 455-468. 10.1083/jcb.200109094.CrossRefPubMedPubMedCentral Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A: DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J Cell Biol. 2002, 157: 455-468. 10.1083/jcb.200109094.CrossRefPubMedPubMedCentral
6.
go back to reference Bursch W, Ellinger A, Kienzl H, Torok L, Pandey S, Sikorska M, Walker R, Hermann RS: Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis. 1996, 17: 1595-1607. 10.1093/carcin/17.8.1595.CrossRefPubMed Bursch W, Ellinger A, Kienzl H, Torok L, Pandey S, Sikorska M, Walker R, Hermann RS: Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis. 1996, 17: 1595-1607. 10.1093/carcin/17.8.1595.CrossRefPubMed
7.
go back to reference Schoenlein PV, Periyasamy-Thandavan S, Samaddar JS, Jackson WH, Barrett JT: Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance. Autophagy. 2009, 5: 400-403. 10.4161/auto.5.3.7784.CrossRefPubMed Schoenlein PV, Periyasamy-Thandavan S, Samaddar JS, Jackson WH, Barrett JT: Autophagy facilitates the progression of ERα-positive breast cancer cells to antiestrogen resistance. Autophagy. 2009, 5: 400-403. 10.4161/auto.5.3.7784.CrossRefPubMed
8.
go back to reference Mizushima N, Levine B, Cuervo AM, Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature. 2008, 451: 1069-1075. 10.1038/nature06639.CrossRefPubMedPubMedCentral Mizushima N, Levine B, Cuervo AM, Klionsky DJ: Autophagy fights disease through cellular self-digestion. Nature. 2008, 451: 1069-1075. 10.1038/nature06639.CrossRefPubMedPubMedCentral
9.
go back to reference Szegezdi E, Logue SE, Gorman AM, Samali A: Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006, 7: 880-885. 10.1038/sj.embor.7400779.CrossRefPubMedPubMedCentral Szegezdi E, Logue SE, Gorman AM, Samali A: Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006, 7: 880-885. 10.1038/sj.embor.7400779.CrossRefPubMedPubMedCentral
10.
go back to reference Gomez BP, Riggins R, Shajahan AN, Klimach U, Wang A, Crawford AC, Zhu Y, Zwart A, Wang M, Clarke R: Human X-Box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J. 2007, 21: 4013-4027. 10.1096/fj.06-7990com.CrossRefPubMed Gomez BP, Riggins R, Shajahan AN, Klimach U, Wang A, Crawford AC, Zhu Y, Zwart A, Wang M, Clarke R: Human X-Box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J. 2007, 21: 4013-4027. 10.1096/fj.06-7990com.CrossRefPubMed
11.
go back to reference Crawford AC, Riggins RB, Shajahan AN, Zwart A, Clarke R: Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis. PLoS ONE. 2010, 5: e8604-10.1371/journal.pone.0008604.CrossRefPubMedPubMedCentral Crawford AC, Riggins RB, Shajahan AN, Zwart A, Clarke R: Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis. PLoS ONE. 2010, 5: e8604-10.1371/journal.pone.0008604.CrossRefPubMedPubMedCentral
12.
go back to reference Nehra R, Riggins RB, Shajahan AN, Zwart A, Crawford AC, Clarke R: BCL2 and CASP8 regulation by NFκB differentially affect mitochondrial function and cell fate in antiestrogen sensitive and resistant breast cancer cells. FASEB J. 2010, 24: 2040-2055. 10.1096/fj.09-138305.CrossRefPubMedPubMedCentral Nehra R, Riggins RB, Shajahan AN, Zwart A, Crawford AC, Clarke R: BCL2 and CASP8 regulation by NFκB differentially affect mitochondrial function and cell fate in antiestrogen sensitive and resistant breast cancer cells. FASEB J. 2010, 24: 2040-2055. 10.1096/fj.09-138305.CrossRefPubMedPubMedCentral
13.
go back to reference Clarke R, Shajahan AN, Wang Y, Tyson JJ, Riggins RB, Weiner LM, Baumann WT, Xuan J, Zhang B, Facey C, Aiyer H, Cook K, Hickman FE, Tavassoly I, Verdugo A, Chen C, Zwart A, Wärri A, Hilakivi-Clarke LA: Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer. Horm Mol Biol Clin Invest. 2011, 5: 35-44. 10.1515/HMBCI.2010.073. Clarke R, Shajahan AN, Wang Y, Tyson JJ, Riggins RB, Weiner LM, Baumann WT, Xuan J, Zhang B, Facey C, Aiyer H, Cook K, Hickman FE, Tavassoly I, Verdugo A, Chen C, Zwart A, Wärri A, Hilakivi-Clarke LA: Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer. Horm Mol Biol Clin Invest. 2011, 5: 35-44. 10.1515/HMBCI.2010.073.
14.
go back to reference Gonzalez-Malerva L, Park J, Zou L, Hu Y, Moradpour Z, Pearlberg J, Sawyer J, Stevens H, Harlow E, LaBaer J: High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci USA. 2011, 108: 2058-2063. 10.1073/pnas.1018157108.CrossRefPubMedPubMedCentral Gonzalez-Malerva L, Park J, Zou L, Hu Y, Moradpour Z, Pearlberg J, Sawyer J, Stevens H, Harlow E, LaBaer J: High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci USA. 2011, 108: 2058-2063. 10.1073/pnas.1018157108.CrossRefPubMedPubMedCentral
15.
go back to reference Moyano JV, Evans JR, Chen F, Lu M, Werner ME, Yehiely F, Diaz LK, Turbin D, Karaca G, Wiley E, Nielsen TO, Perou CM, Cryns VL: αB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest. 2006, 116: 261-270.CrossRefPubMedPubMedCentral Moyano JV, Evans JR, Chen F, Lu M, Werner ME, Yehiely F, Diaz LK, Turbin D, Karaca G, Wiley E, Nielsen TO, Perou CM, Cryns VL: αB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest. 2006, 116: 261-270.CrossRefPubMedPubMedCentral
Metadata
Title
Cannibalism, cell survival, and endocrine resistance in breast cancer
Author
Robert Clarke
Publication date
01-08-2011
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 4/2011
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2870

Other articles of this Issue 4/2011

Breast Cancer Research 4/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine